Time Source Company Announcement
15 Apr 2026 10:30 AM Director/PDMR Shareholding
15 Apr 2026 10:29 AM 20260414_PERMANENT TSB GROUP_38.5 (b)_IE_BOFASE
15 Apr 2026 10:26 AM 20260414_PERMANENT TSB GROUP_38.5 (a)_IE_MLI
15 Apr 2026 10:25 AM Director/PDMR Shareholding
15 Apr 2026 10:19 AM Director/PDMR Shareholding
15 Apr 2026 10:17 AM Credit Rating
15 Apr 2026 10:16 AM Director/PDMR Shareholding
15 Apr 2026 10:06 AM Director/PDMR Shareholding
15 Apr 2026 10:04 AM Holding(s) in Company
15 Apr 2026 09:50 AM Director/PDMR Shareholding
15 Apr 2026 09:30 AM Notice of Annual General Meeting
15 Apr 2026 09:29 AM Result of AGM
15 Apr 2026 09:24 AM Notification of Transactions of Directors/PDMRs
15 Apr 2026 09:17 AM Annual Report and Accounts 2025 and Notice of AGM
15 Apr 2026 09:11 AM Form 38.5(a) (EPT/NON-RI)
15 Apr 2026 09:09 AM Standard form for notification of major holdings
15 Apr 2026 09:00 AM Publication of 2025 Annual Report and Accounts
15 Apr 2026 09:00 AM Director/PDMR Shareholding
15 Apr 2026 08:45 AM Application for block admission to trading
15 Apr 2026 08:24 AM Transaction in Own Shares
15 Apr 2026 08:18 AM Holding(s) in Company
15 Apr 2026 08:15 AM Stabilisation Notice
15 Apr 2026 08:00 AM TE Announces its Dividend Distribution Dates
15 Apr 2026 08:00 AM Schedule One Update - Oscillate PLC
15 Apr 2026 07:30 AM Covenant Waiver Extension
15 Apr 2026 07:30 AM Suspension - Tiger Alpha Plc
15 Apr 2026 07:14 AM Transaction in Own Shares & Rule 2.9 Announcement
15 Apr 2026 07:13 AM Grant of Employee Share Rights
15 Apr 2026 07:13 AM Exercise and Lapse of Equity Incentive Securities
15 Apr 2026 07:12 AM GSK completes acquisition of 35Pharma Inc.
15 Apr 2026 07:05 AM Half-year Financial Report
15 Apr 2026 07:01 AM Director Appointment
15 Apr 2026 07:01 AM First Compulsory Redemption and Timetable
15 Apr 2026 07:01 AM Obsidian Therapeutics reverse merger with Galera
15 Apr 2026 07:00 AM Portfolio News: 2D Photonics subsidiary grant
15 Apr 2026 07:00 AM Heads of Terms signed with Potentially Limited
15 Apr 2026 07:00 AM Notice of Q1 Trading Update
15 Apr 2026 07:00 AM Update on Intention to Move to Main Market
15 Apr 2026 07:00 AM Fundraise of £750,000
15 Apr 2026 07:00 AM Operational Update: Subnet 46 (RESI)
15 Apr 2026 07:00 AM Change to Significant Shareholder Interest
15 Apr 2026 07:00 AM Publication of 2025 Sustainability Report
15 Apr 2026 07:00 AM Unaudited Portfolio Valuation as at 31 March 2026
15 Apr 2026 07:00 AM Q2 2026 Update and CEO Interviewed on Vox Markets
15 Apr 2026 07:00 AM Online Investor Presentation and Q&A Session
15 Apr 2026 07:00 AM Investor Presentation
15 Apr 2026 07:00 AM Presentation at 18th Annual World Cancer Congress
15 Apr 2026 07:00 AM Participation in Water Tower Research Conference
15 Apr 2026 07:00 AM Cross-Trading on the U.S. OTCQX Market
15 Apr 2026 07:00 AM SELP JV PRICES €500 MILLION 3.875% UNSECURED BONDS
UK 100

Latest directors dealings